Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. (2019)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-019-0823-5
PubMed Identifier: 31043708
Publication URI: http://europepmc.org/abstract/MED/31043708
Type: Journal Article/Review
Volume: 38
Parent Publication: Oncogene
Issue: 28
ISSN: 0950-9232